Income Taxes (Details Narrative) - USD ($) $ in Millions |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2026 |
|
| Operating Loss Carryforwards [Line Items] | |||
| Deferred tax assets, capital loss carryforwards | $ 54.8 | $ 36.0 | |
| Net operating loss carryforward, expiration date | 2037 | ||
| Net operating loss carryforward term | 20 years | ||
| Income tax examination description | Pursuant to Code Sec. 382 of the Internal Revenue Code (“the Code”), the utilization of our net operating loss carryforwards could be limited as a result of a cumulative change in stock ownership of more than 50% over a three-year period. We have not completed a Sec. 382 study and as such our net operating loss carryforwards may be subject to such limitation | ||
| Deferred tax assets capitalized research and development net of amortization | $ 3.8 | ||
| Unamortized balance from research and development expenditures | 50.00% | 50.00% | |
| Valuation allowance deferred tax asset | $ 1.4 | $ 2.3 | |
| Federal [Member] | |||
| Operating Loss Carryforwards [Line Items] | |||
| Net operating loss carryforwards | $ 54.5 | ||
| X | ||||||||||
- Definition Deferred tax assets capitalized research and development net of amortization. No definition available.
|
| X | ||||||||||
- Definition Net operating loss carryforward, expiration date. No definition available.
|
| X | ||||||||||
- Definition Net operating loss carryforward term. No definition available.
|
| X | ||||||||||
- Definition Unamortized balance from research and development expenditures. No definition available.
|
| X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible capital loss carryforwards. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition A brief description of status of the tax examination, significant findings to date, and the entity's position with respect to the findings. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|